Chinese English Espanol


Industry News

Home > News > Industry News
FDA approved treatment is pro-drug TKM-Ebola Ebola virus as soon as possible
Published: 2014/8/28 17:39:48
According to Taiwan, "BBC News" reported on July 31, the international health community by attending "change" Web site ( led, July 30 to the Federal Food and Drug Administration (FDA) petitioned the FDA approved one as soon as possible drug TKM-Ebola, this drug is considered for the treatment of Ebola have effects.

Allegedly, the drug developed by Tekmira Pharmaceuticals Canada, to kill primates quite effective Ebola virus, began the first phase of human clinical trials early in 2014, but in July 2014, FDA announced a ban on clinical trials, the reason is that the trial is a volunteer for the object. In fact, the 14 objects involved in the trial are safe and sound.

February 2014 outbreak of Ebola virus in West Africa (Ebola) since the disease has caused the death of 672 people, even as far away as East Asia, Hong Kong on the 30th also reported suspected cases. Because Ebola virus is still without a cure, the mortality rate may be as high as 90%, the epidemic sparked concern.

The United States plans to start in September this year Ebola vaccine human trials

National Institutes of Health (NIH) Joint Food and Drug Administration (FDA) plans to start as early as September this year Ebola vaccine Phase I clinical trials, and in early January next year the results.

Research Institutes of Health report quoted said the research and development of vaccines in mammalian test results "gratifying." If satisfactory clinical results, the vaccine is expected to come out in 2015.

According to World Health Organization data show that the Ebola virus outbreak in West Africa, has now infected more than 1300 people, killing 729 people, the mortality rate as high as 90%, currently no vaccine or effective therapeutic approach.
Prev:Baiyun Mountain, chairman of the three types of generic drug...
Next:China Cardiovascular Diabetes drug development companies old...
Copyright © SHANGHAI SHARING TECHNOLOGIES CO., LTD. All rights reserved